Elanix Biotechnologies AG Logo

Elanix Biotechnologies AG

Develops products from progenitor cells for wound care and dermatological applications.

ELN | F

Overview

Corporate Details

ISIN(s):
DE000A0WMJQ4
LEI:
391200SYNFFL0NPAJK90
Country:
Germany
Address:
Hanauer Landstrasse 291, 60314 Frankfurt am Main

Description

Elanix Biotechnologies AG is a tissue regeneration company that develops and commercializes products for acute wound care, dermatological, and gynecological applications. The company's core focus is on creating therapeutic solutions derived from progenitor cells. Its product development pipeline aims to provide advanced treatments for skin and tissue repair.

Social Media

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2019-06-25 13:47 English 14.0 KB
2019-06-20 18:54 English 14.5 KB
2019-06-20 18:50 English 14.5 KB
2019-06-20 18:46 English 14.5 KB
2019-05-13 07:26
Elanix Biotechnologies AG: CRIMINAL CHARGES HAVE BEEN FILED AGAINST THE FORMER …
English 7.5 KB
2019-04-18 09:30
Elanix Biotechnologies AG: NOMINATION OF THE CHAIRMAN OF THE SUPERVISORY BOARD,…
English 4.9 KB
2019-03-27 19:00
Elanix Biotechnologies AG: Correction of 2015 Financial Statements - Release ac…
English 7.3 KB
2019-02-14 09:21
Elanix Biotechnologies AG: Resignation in Supervisory Board
English 6.1 KB
2019-02-14 00:47
Elanix Biotechnologies AG: Criminal charges to be filed against former CEO Toma…
English 6.5 KB
2019-02-11 07:58
Elanix Biotechnologies AG annuls profit guidance and preliminary earnings for F…
English 7.0 KB
2019-02-07 14:03
Elanix Biotechnologies AG: Major Shareholder requests extraordinary general ass…
English 6.7 KB
2018-12-19 20:20 English 4.6 KB
2018-12-19 18:42 English 14.0 KB
2018-12-12 18:00 English 13.9 KB
2018-11-30 22:00 English 13.9 KB

Automate Your Workflow. Get a real-time feed of all Elanix Biotechnologies AG filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Elanix Biotechnologies AG

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Elanix Biotechnologies AG via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

4BASEBIO PLC Logo
Manufactures GMP-grade synthetic DNA for next-generation therapeutics and vaccines.
United Kingdom
4BB
4D Molecular Therapeutics, Inc. Logo
Develops genetic medicines using AAV vectors for ophthalmology and pulmonology diseases.
United States of America
FDMT
4SC AG Logo
Biopharmaceutical company with no products under development or operational business.
Germany
VSC
60 DEGREES PHARMACEUTICALS, INC. Logo
Develops and commercializes medicines for infectious diseases, focusing on tropical illnesses.
United States of America
SXTP
89bio, Inc. Logo
Clinical-stage biopharma developing therapies for liver and cardiometabolic diseases.
United States of America
ETNB
Aardvark Therapeutics, Inc. Logo
Clinical-stage biopharma developing therapeutics for hunger and metabolic diseases.
United States of America
AARD
ABBOTT LABORATORIES Logo
Global healthcare company in medical devices, diagnostics, nutrition & pharmaceuticals.
United States of America
ABT
AbbVie Inc. Logo
A research-based biopharmaceutical company developing and manufacturing medicines.
United States of America
ABBV
AbCellera Biologics Inc. Logo
Discovers and develops antibody-based therapeutics using a proprietary platform.
United States of America
ABCL
Develops antibody-based therapeutics using CAR-T, NEST, and AffiMab platforms.
South Korea
174900

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.